AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 294: E110-E119, 2008. First published November 6, 2007; doi:10.1152/ajpendo.00407.2007
0193-1849/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/E110    most recent
00407.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romestaing, C.
Right arrow Articles by Sibille, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romestaing, C.
Right arrow Articles by Sibille, B.

Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet

Caroline Romestaing,1 Marie-Astrid Piquet,2 Dominique Letexier,1 Benjamin Rey,1 Arnaud Mourier,4 Stéphane Servais,1 Maud Belouze,1 Vincent Rouleau,2 Marianne Dautresme,2 Isabelle Ollivier,2 Roland Favier,3 Michel Rigoulet,4 Claude Duchamp,1 and Brigitte Sibille1

1Laboratoire de Physiologie Intégrative, Cellulaire et Moléculaire, UMR 5123 Centre National de la Recherche Scientifique, Lyon; 2Imagerie Fonctionnelle et Métabolique en Oncologie, Service d'hépatogastroentérologie et de nutrition, Centre Hospitalier Universitaire Caen; 3Laboratoire de Bioénergétique Fondamentale et Appliquée, Institut National de la Santé et de la Recherche Médicale, Grenoble, France; and 4Laboratoire Régulation du Métabolisme Energétique Cellulaire, UMR 5095, Centre National de la Recherche Scientifique, Institut de Biochimie et Génétique Cellulaires, Bordeaux, France

Submitted 27 June 2007 ; accepted in final form 5 November 2007


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Nonalcoholic fatty liver disease (NAFLD) has become common liver disease in Western countries. There is accumulating evidence that mitochondria play a key role in NAFLD. Nevertheless, the mitochondrial consequences of steatohepatitis are still unknown. The bioenergetic changes induced in a methionine- and choline-deficient diet (MCDD) model of steatohepatitis were studied in rats. Liver mitochondria from MCDD rats exhibited a higher rate of oxidative phosphorylation with various substrates, a rise in cytochrome oxidase (COX) activity, and an increased content in cytochrome aa3. This higher oxidative activity was associated with a low efficiency of the oxidative phosphorylation (ATP/O, i.e., number of ATP synthesized/natom O consumed). Addition of a low concentration of cyanide, a specific COX inhibitor, restored the efficiency of mitochondria from MCDD rats back to the control level. Furthermore, the relation between respiratory rate and protonmotive force (in the nonphosphorylating state) was shifted to the left in mitochondria from MCDD rats, with or without cyanide. These results indicated that, in MCDD rats, mitochondrial ATP synthesis efficiency was decreased in relation to both proton pump slipping at the COX level and increased proton leak although the relative contribution of each phenomenon could not be discriminated. MCDD mitochondria also showed a low reactive oxygen species production and a high lipid oxidation potential. We conclude that, in MCDD-fed rats, liver mitochondria exhibit an energy wastage that may contribute to limit steatosis and oxidative stress in this model of steatohepatitis.

nonalcoholic steatohepatitis; mitochondria; uncoupling


NONALCOHOLIC STEATOHEPATITIS (NASH) is a disease of emerging importance, associated with obesity and insulin resistance and is now considered as a common cause of chronic liver disease in the United States (3, 11, 25). There is growing evidence that obesity-related insulin resistance in skeletal muscles and adipose tissue causes hepatic lipid accumulation that is harmful to the liver. Although the reasons for the deleterious effects of fat remain unclear, steatosis has been associated with lipid peroxidation, increased tumor necrosis factor (TNF)-{alpha} expression, and finally mitochondrial dysfunctions in the successive steps of the pathogenesis of NASH (2, 39). It now appears that mitochondrial dysfunction may play a crucial role in the genesis of NASH, since mitochondria are involved in fatty acid β-oxidation and are the most important source of cellular reactive oxygen species (ROS; see Ref. 23). However, long-term consequences of steatohepatitis on mitochondrial bioenergetics are poorly documented. In patients with NASH, liver mitochondria show ultrastuctural abnormalities and impaired function (9, 49). Nevertheless, because of the difficulty in obtaining sufficient tissues from liver biopsies of patients with NASH, only a few studies have directly addressed the activity and control of mitochondrial complexes of the respiratory chain, and those studies remained superficial.

To overcome the difficulty in obtaining human tissue, rodent models of steatohepatitis have been developed. Nevertheless, current models do not really reflect the human pathology linked to abdominal obesity and/or insulin resistance or are not physiological. One of the most-used models involves rats fed a methionine- and choline-deficient diet (MCDD; see Refs. 22 and 24). The lack of methionine reduces glutathione synthesis and impairs the antioxidant defense against free radical attacks. In addition, the choline deficiency impairs lipid exportation, since choline is required to form the phosphatidylcholine of very low density lipoprotein (VLDL) particles, which transport fat from liver to peripheral tissues. When the supply of choline is inadequate, VLDL cannot be synthesized, leading to a reduction in fatty acid exportation and fat accumulates in liver (27). MCDD does not perfectly mimic the pathogenesis of human NASH that is associated with obesity and insulin resistance, but the advantage of this diet (22) is that it induces progressive fibrosing steatohepatitis that is histologically similar to human NASH and thus appears as a suitable model for studying the consequences of an established steatohepatitis on liver function. A number of studies have used MCDD-fed rats to investigate the mechanism of inflammation (51, 54), which couples steatosis and oxidative stress, but none has addressed the consequences of such diet on mitochondrial bioenergetics and potential adaptations to this steatohepatitis model.

Our aim was to investigate the bioenergetics of liver mitochondria in a dietary model of steatohepatitis in rodents. The effects of steatohepatitis induced by a long-term (6-wk) MCDD on energy metabolism of liver mitochondria and the modifications of oxidative phosphorylation were investigated in vitro.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals and Diet

Our study was performed following the recommendations provided by the European Convention for the protection of Vertebrate Animals used for Experimental and Scientific purposes (Council of Europe No. 123, Strasbourg, 1985). Laboratory staff and rooms were accredited by the French ministry of agriculture (no. 692660602). Male Wistar rats, which were purchased from Charles River Laboratories (France), were housed four per cage under a 12:12-h light-dark cycle. Animals were allowed to acclimatize to their new conditions for 1 wk before the beginning of the study. From the age of 9 wk until 15 wk, rats were separated in two different groups and received either a control diet (n = 12) consisting of the usual pellet rat chow A04 (Scientific Animal Food Engineering) or a high-fat (25% energy derived from fat) MCDD (n = 12) provided in small pellets from ICN Pharmaceuticals (no. 960439) during 6 wk. At the beginning of the study, rats from the two groups had the same weight (control: 292 ± 3 g and MCDD 293 ± 4 g). Rats had free access to food and water and were weighed every week for the duration of the study. Food intake was monitored daily. The choice of the diet and the duration of the study were based on previous studies (24, 51). For the different experiments, one control rat and one MCDD rat were studied each day.

Tissue Preparation and Biochemical Analysis

At the end of the study, animals were killed, and a small piece of liver was removed and fixed in 4% formaldehyde for histological assessment. Blood, liver, and white adipose tissue (retroperitoneal + epididymal) samples were also collected, weighed, and frozen in liquid nitrogen for later analysis. The rest of the liver was used for mitochondria isolation.

Histopathology. Histological analyses were performed in the gastroenterology service of Caen hospital, France. The liver specimens were fixed in 10% buffered formalin for 24–48 h. They were then embedded in paraffin, cut at 5 µm, and routinely stained with hematoxylin-eosin and reticulin. Severity of steatosis was evaluated using the percentage of macrovesicular fat within hepatocytes, i.e., mild (5–30%), moderate (30–60%), and severe (>60%; see Ref. 46). Necroinflammation was histologically quantified by counting inflammatory foci.

Biochemical analysis. A small piece of liver (50 mg) was hydrolyzed in ethanolic KOH for measurement of triacylglycerol (TG) content in lipid extracts (18) by a colorimetric method using a commercial kit (Biomerieux). Blood was collected from the inferior vena cava, plasma was prepared, and aliquots were stored at –80°C until analysis. TG, alanine transaminase (ALT), and aspartate transaminase (AST) were measured from plasma and assayed spectrophotometrically using a commercial kit (TG: ref 61236; ALT: ref 63312; AST: ref 63212; Biomerieux).

Mitochondria Preparation and Oxygen Consumption

Mitochondria were isolated from liver and prepared in a medium containing (in mM) 250 sucrose, 2 KH2PO4, 1 EGTA, and 20 Tris·HCl (pH 7.2). Liver mitochondria were prepared according to standard differential centrifugation procedures (12). Mitochondrial protein content was determined by the biuret method (20), with BSA as standard. For oxygen consumption measurement, mitochondria were incubated at a final concentration of 1 mg/ml in an oxygraph cuvette with a Clark electrode. All experiments, except for ROS production (30°C), were done at 37°C in the following buffer (in mM): 125 KCl, 1 EGTA, 2 KH2PO4, and 20 Tris·HCl (pH 7.2). The control (nonphosphorylating) state of respiration was initiated by the addition of different substrates (6.25 mM glutamate/1.25 mM malate or 5 mM succinate/0.5 mM malate + 1.25 µM rotenone or 100 µM octanoyl-carnitine). State 3 (phosphorylating respiration) was obtained after the addition of 1 mM ADP. Oligomycin (1.25 µg/mg proteins), a specific inhibitor of the mitochondrial ATP synthase, was then added to the mitochondrial suspension to determine the nonphosphorylating respiratory rate (state 4). The efficiency of the mitochondrial oxidative phosphorylation was assessed by the state 3-to-state 4 ratio, which measures the degree of control imposed on oxidation by phosphorylation (respiratory control ratio, RCR), in the absence of any kinetic control upstream from phosphorylation processes. All experiments were done in the presence of free fatty acid (FFA)-BSA to rid the medium of FFA that might induce an uncoupling of the oxidative phosphorylation. A titration of mitochondrial respiration with FFA-BSA was done in both groups. The minimal concentration of FFA-BSA leading to optimal RCR was determined at a final concentration of 3 mg/ml (0.3% wt/vol; data not shown).

Cytochrome c oxidase (COX) activity was measured in the buffer used for the respiration assay supplemented with 5 mM ascorbate, 1–2 mM N,N,N'N'-tetramethyl-p-phenylenediamine (TMPD), 3.6 µM myxothiazol, and 75 µM 2,4-dinitrophenol (DNP).

The yield of oxidative phosphorylation, assessed by ATP/O ratio, was determined from the ATP synthesis rate (JATP) vs. respiratory rate (JO2) with an ADP-regenerating system, based on hexokinase plus glucose. Rat liver mitochondria (1 mg/ml) were suspended in the respiration buffer, added with 20 mM glucose, 1 mM MgCl2 and 125 µM ATP. Oxygen consumption, in the presence of 5 mM succinate/0.5 mM malate plus 1.25 µM rotenone, and ATP synthesis were titrated by addition of increasing concentrations of hexokinase (0.2–2 U/ml). Mitochondrial suspension (300 µl) was withdrawn from the cuvette, quenched in HClO4 (4% vol/vol final concentration), and neutralized with 2 M KOH/0.3 M MOPS for enzymatic measures. Production of ATP was determined by monitoring glucose 6-phosphate formation (4).

Measurement of Proton Conductance in Liver Mitochondria

The respiration rate of mitochondria, in the presence of oligomycin to inhibit ATP synthesis, is proportional to the loss of energy across the mitochondrial inner membrane. The kinetic response of the proton conductance to its driving force (protonmotive force; {Delta}p) can therefore be estimated as the relation between respiration rate and mitochondrial membrane potential if one considers the H+/O ratio to remain constant (29).

Measurement of {Delta}{Psi} with TPMP+ electrode. Respiration rate and membrane potential were determined simultaneously by using electrodes sensitive to oxygen and to the potential-dependent triphenylmethylphosphonium cation (TPMP+). Mitochondria (1 mg/ml) were incubated at 37°C in the respiration buffer containing 5 µM rotenone, 1 µg/ml oligomycin, and 65 ng/ml nigericin (to collapse the pH difference across the mitochondrial inner membrane). The electrode was calibrated with sequential TPMP+ additions, up to 2 µM, and 4 mM succinate was added to start the reaction. Respiration and potential were gradually inhibited through successive steady states by additions of malonate up to 3 mM. At the end of each run, 0.4 µM p-trifluoromethoxyphenylhydrazone was added to dissipate the membrane potential and release all TPMP+ in the buffer, allowing correction for any small electrode drift. The TPMP+ binding correction factor was previously assessed as being 0.38 (15).

Determination of matrix volume, {Delta}{Psi}, and {Delta}pH with labeled probes. Mitochondria (4 mg/ml) were incubated at 37°C in the same respiration buffer containing 8 mM succinate and 1 µg/ml oligomycin. Matrix volume was determined by using [3H]water and inner membrane impermeable [14C]mannitol, and {Delta}{Psi} and {Delta}pH by distribution of [14C]TPMP and [3H]acetate, respectively. After equilibration (3 min), mitochondria were pelleted by rapid centrifugation (12,000 g; 30 s), and, within 10 s, 100 µl of the supernatant were removed and placed in a vial containing 4 ml of a liquid scintillation cocktail (ULTIMA GOLD; Perkin-Elmer), and the remainder was aspired. The pellet was resuspended in 300 µl of 10% HClO4 (vol/vol) and centrifuged (12,000 g; 30 s), and 260 µl of the supernatant were treated as above (15).

Respiration rates (state 4 and 3), ATP/O ratio, and {Delta}p were also measured in the presence of a specific inhibitor of COX, sodium cyanide (NaCN) added to the MCDD group. A titration with small amounts of NaCN was done to determine the concentration required to raise the respiration rate of MCDD mitochondria to the control level (12–17 µM).

Mitochondrial H2O2 Production

The rate of released mitochondrial H2O2 was measured at 30°C by monitoring the linear increase in fluorescence ({lambda}ex = 312 nm and {lambda}em = 420 nm) resulting from the oxidation of Homovanillic acid (HVA) by H2O2 in the presence of horseradish peroxidase (HRP) with an SFM-25 fluorometer (Kontron Instruments, Dardilly, France). Reaction conditions were 0.5 mg of mitochondrial protein/ml, 6 U/ml HRP, 0.1 mM HVA, 5 mM succinate, and 0.3% FFA-BSA (wt/vol) in the respiration buffer. Known concentrations of H2O2 were used to establish the standard concentration curve.

Mitochondrial Cytochrome Content

The different cytochromes of the mitochondrial respiratory chain were measured by dual-wavelength spectrophotometry at 30°C by comparing the spectra of fully oxidized vs. fully reduced cytochromes (55). In each of the two cuvettes, 5 mg of mitochondrial protein, 1 ml of 0.1 M sodium phosphate, pH 7.4, and 0.01% (vol/vol) Triton X-100 were added. In the "oxidized" cuvette, 10 µl of ferricyanide (0.5 M) were added while a few grains of sodium hydrosulfite were added in the "reduced" cuvette. The components were mixed, and the spectrums of both cuvettes were recorded. A typical difference between reduced minus oxidized spectra was obtained. Wavelength pairs and absorption coefficient used were: cytochrome c + c1 (550–540 nm) {varepsilon} = 18 mM–1/cm, cytochrome b (563–575 nm) {varepsilon} = 18 mM–1/cm and cytochrome a + a3 (605–630 nm) {varepsilon} = 24 mM–1/cm.

Antioxidant Enzyme Activities

A portion of frozen liver was homogenized with a potter Elvehjem, at 4°C, in a buffer containing (in mM) 100 KH2PO4, 1 dithiothreitol, and 2 EDTA, pH 7.4. After centrifugation (3,000 g for 5 min), the supernatant was used for enzymatic assays. Superoxide dismutase (SOD) activity was assayed by monitoring the rate of acetylated cytochrome c reduction by superoxide radicals generated by the xanthine-xanthine oxidase system (16). One activity unit of SOD was defined as the amount of enzyme that inhibited the rate of acetylated cytochrome c reduction by 50%. To distinguish manganese SOD, exclusively located in the mitochondrial matrix, from copper/zinc SOD, which is primarily located in the cytosol, SOD activity was determined after incubation with NaCN (1 mM). At this concentration, cyanide inhibited the copper,zinc isoform of the enzyme but did not affect the manganese isoform (16). The assay for total activity of glutathione peroxidase (GPx) coupled the reduction of cumene hydroperoxide to the oxidation of NADPH by glutathione reductase, and this coupled reaction was monitored at 340 nm (53). The activity of catalase (CAT) was determined by the method of Aebi (1). This technique uses the first-order rate constant of the decomposition of H2O2 by tissue CAT at 20°C. One unit of CAT activity was calculated by using k = (2.3/dt)(log A1/A2), where k is CAT activity, dt is change in time, A1 is initial absorbance, and A2 is final absorbance. All enzyme activities are expressed as units per milligram protein.

Citrate Synthase Activity

Citrate synthase activity was used as a mitochondrial enzymatic marker. Liver homogenates were added to a buffer with 100 mM Tris·HCl, 1 mM 5,5'-dithiobis-2-nitrobenzoic acid, 3 mM acetyl-CoA, pH 8, containing 0.2% (vol/vol) Triton X-100. The reaction was started by the addition of 1 mM oxaloacetate, and the initial rate was measured following the decrease of absorbance at 420 nm (50). All enzyme activities are expressed as units per minute per milligram protein. No significant variation in the activity of citrate synthase was found between preparations from control and MCDD livers (53 ± 4 vs. 49 ± 2 U·min–1·mg protein–1).

RNA Extraction and RT-PCR

Total RNA was extracted from liver samples (80 mg) of five control and five MCDD-fed rats using TRIzol (Invitrogen, Cergy Pontoise, France). The relative abundance of target mRNA for interleukin-6 (IL-6), TNF-{alpha}, and TNF receptor 1 (TNF-R) was measured by semiquantitative RT-PCR using cyclophilin as reference. Total RNA (1 µg) was reverse-transcribed for 1 h at 42°C using Moloney murine leukemia virus reverse transcriptase (Promega, Charbonnières, France) and oligo(dT) primer following the manufacturer's protocol. PCR reactions were carried out with 2.5 µl of cDNA as template for EurobioTaq DNA polymerase (Eurobio, Courtaboeuf, France) as described by the manufacturer. PCR was performed for 23, 36, 32, and 27 cycles with primers specific of cyclophilin, IL-6, TNF-{alpha}, and TNF-R. Each cycle consisted in 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min, and the complete sequence was followed by a final elongation step of 10 min at 72°C. PCR primer pairs were designed to be functionally active at 60°C annealing temperature. Products were analyzed on 1.5% agarose gels prestained with ethidium bromide. For quantitation of relative bands intensities, pictures were taken with a Camera DC120 (Kodak), and the ratio of each target was determined with Kodak Digital Science 1D 2.0 (Kodak Scientific Imaging System). The extent of target gene expression was given as a relative unit, which was defined as the quotient of target gene expression vs. cyclophilin gene expression.

Statistical Analysis

All data were expressed as mean values ± SE. Statistical comparisons were done using ANOVA followed by Fischer's test to determine difference between the standard and MCDD group. Correlations were assessed by linear regression.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Effects of MCDD on Rat Physiological Characteristics

After 6 wk of diet, MCDD-fed rats weighed less than controls (Table 1). Most of the weight loss occurred during the first 2 wk of diet (data not shown). Such a loss of weight is a common feature of the MCDD (24, 51). The estimated daily caloric intake per rat followed the same profile as body weight (Table 1). However, when expressed per 100 g body wt, the caloric intake was identical for the two groups (16–17 kcal·100 g–1·day–1). Apart from weight loss, the general condition of the animals under MCDD remained satisfactory as described by Kirsch et al. (24).


View this table:
[in this window]
[in a new window]

 
Table 1. Physiological characteristics of rats fed a control or a MCDD for 6 wk

 
To understand the difference in body mass between the two groups, different tissues were taken and weighed, and, to take into account those differences in body mass, tissue mass was expressed per 100 g of body mass. MCDD-fed rats showed a 60% reduction in white adipose tissue relative mass compared with the control group, whereas liver relative mass was increased by 34% (Table 1). Six weeks of diet affected lipid distribution. Indeed, although peripheral fat depots were reduced, hepatic TG content (Table 1) was increased markedly in MCDD rats, i.e., 476 ± 14 vs. 6.4 ± 0.5 µmol/g in MCDD and control rats, respectively (P < 0.001). In contrast, plasma TG content was reduced significantly in MCDD rats, i.e., 0.3 ± 0.1 vs. 2 ± 0.3 µmol/g (P < 0.001, Table 1). Macroscopically, the liver from MCDD rats appeared pale and fatty compared with controls. Histological examination (Fig. 1) revealed a severe macrovesicular steatosis, affecting >60% of MCDD rat hepatocytes, and inflammatory sites with the presence of microgranulomas of macrophages. Necrosis was a minor feature while fibrosis was absent.


Figure 1
View larger version (39K):
[in this window]
[in a new window]

 
Fig. 1. Histological appearance of liver from control or methionine- and choline-deficient diet (MCDD)-fed rats. Liver samples were stained with hematoxylin and eosin (magnification x10); lipid vesicles are pointed out by a black arrow and inflammation by a white arrow. The liver of control rats did not show any fat accumulation, whereas MCDD rat liver showed pronounced macrovesicular hepatic steatosis and inflammatory cells.

 
Semiquantitative RT-PCR was used to investigate the expression in liver of a number of genes known to be upregulated during inflammation. The relative abundance of mRNA encoding IL-6, TNF-{alpha}, and TNF-R was higher, i.e., +437, +212, and +46%, respectively (P < 0.01), in MCDD than in control rat liver (Fig. 2). This finding confirmed the results of our histological study and the occurrence of inflammation in MCDD rat liver. Moreover, plasma ALT and AST levels, the markers of liver cell damage, were significantly higher in MCDD than in control rats (Table 1).


Figure 2
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 2. Expression of inflammatory gene markers in rat liver. RT-PCR analysis of interleukin (IL)-6, tumor nocrosis factor (TNF)-{alpha}, and TNF receptor (TNF-R) gene expression in rat liver using specific primers. Cyclophilin was used as an invariant gene. Two animals per group are presented, but analysis was performed on 5 rats in each group.

 
Rats Fed MCDD Showed Increased Respiration in Liver Mitochondria

Oxidative phosphorylation parameters in isolated mitochondria from control and MCDD rats are presented in Table 2. The state 3 respiratory rate obtained after the addition of ADP was increased by 45% with either glutamate/malate or succinate/malate in MCDD rat mitochondria. State 4 was also higher in MCDD mitochondria (+45–55%). MCDD mitochondria have the same RCR than the control mitochondria and this, whatever the substrate considered.


View this table:
[in this window]
[in a new window]

 
Table 2. Oxygen consumption from isolated liver mitochondria

 
To further investigate the oxidative phosphorylation process, its yield was assessed by studying the ATP/O relation. As previously reported (17, 31), this relation is linear when these fluxes are modulated by addition of various hexokinase concentrations. The straight line obtained with MCDD rat mitochondria was parallel to that found in controls but was shifted to the right (Fig. 3A). In other words, to reach a similar ATP synthesis, MCDD rat mitochondria required a higher level of oxygen consumption. The following two mechanisms could be involved in this drop in mitochondrial efficiency: a change in the proton conductance of the mitochondrial inner membrane, i.e., proton leak, and/or a decrease in the efficiency in the coupling between electron and proton flux through the respiratory chain, i.e., redox slipping (41, 42).


Figure 3
View larger version (11K):
[in this window]
[in a new window]

 
Fig. 3. Relation between ATP synthesis and oxygen consumption (A) and respiratory rate (JO2) and protonmotrice force ({Delta}p) in isolated liver mitochondria (B). A: relation between ATP synthesis and oxygen consumption (ATP/O) was measured in rat liver mitochondria (1 mg/ml) suspended in the following buffer (in mM): 125 KCl, 1 EGTA, 2 KH2PO4, and 20 Tris·HCl (pH 7.2; 37°C) supplemented with 5 mM succinate, 0.5 mM malate, 1.25 µM rotenone, 20 mM glucose, 125 µM ATP, and 1 mM MgCl2. Oxygen consumption and ATP synthesis were titrated by addition of increasing concentrations of hexokinase (0.2–2 U/ml). ATP production was monitored by glucose 6-phosphate formation, which was measured enzymatically. B: the relation between oxygen consumption rate and membrane potential was measured in the same buffer as above, in the presence of 5 mM succinate, 5 µM rotenone, 1 µg/ml oligomycin, and 65 ng/ml nigericin. Respiration rate and membrane potential were inhibited by addition of malonate. Results are expressed as means ± SE; n = 5–7 animals in each group.

 
Because the decrease in the mitochondrial energy transfer efficiency was observed in state 4 respiration rate (Table 2), we examined the relation between JO2 and {Delta}p in this nonphosphorylating condition (29). To compare the two sets of mitochondria, we determined the matrix volume, {Delta}{Psi}, and {Delta}pH using labeled probes. As shown in Table 3, the matricial volume, {Delta}{Psi}, and {Delta}pH were identical in both groups in state 4. From these data, {Delta}p was calculated, and it was found to be similar to the {Delta}{Psi} measured with a TPMP+ electrode taking into account the measured matrix volume (Table 3).


View this table:
[in this window]
[in a new window]

 
Table 3. Matrix volume and protonmotive force in isolated mitochondria of control and MCDD rats

 
The relation between the respiratory rate and the {Delta}p was determined by using succinate as substrate and by modulating the respiration rate with malonate, an inhibitor of the dicarboxylate carrier and succinate dehydrogenase. As classically reported, this relation was nonlinear (Fig. 3B and Ref. 29). However, the curve was shifted to the left side for MCDD mitochondria. Hence, the highest {Delta}p, which was identical in both groups, was obtained at a higher respiratory rate for MCDD rat mitochondria than for control mitochondria, i.e., 39 ± 4 vs. 27 ± 2 nmol O2·min–1·mg protein–1 (P < 0.05). An increased proton leak could explain, in part only, this shift of the curve, since, contrary to what was observed in our study, it is well known that a proton leak effect induced by a protonophore addition increases the respiratory rate in response to a decrease in {Delta}p (6, 28). Some degree of redox slipping can therefore not be excluded.

COX, the last component of the respiratory chain, is well recognized as a controlling step in nonphosphorylating oxygen consumption (40) and as a site of "energy wastage" by redox slipping (10, 35). Maximal mitochondrial COX activity was evaluated by an uncoupled respiratory rate (+DNP) with TMPD-ascorbate, an electron donor to COX, as substrate. In MCDD rat mitochondria, maximal COX activity was higher than in controls, i.e., +54% (Table 2), which was consistent with a higher content in cytochrome aa3 (+49%; P < 0.05; Table 4). From our finding, it is clear that the modification in mitochondria oxidative phosphorylation is linked to an increase in the COX content in MCDD mitochondria. This finding and various data from the literature support a relation between COX content (33) and the altered efficiency of the respiratory chain in MCDD mitochondria.


View this table:
[in this window]
[in a new window]

 
Table 4. Liver mitochondria cytochrome content

 
To further investigate the role of COX activity in the increased state 4 respiratory rate of the MCDD mitochondria, we measured the ATP/O ratio (Fig. 4A) in the presence of NaCN (12–17 µM), a specific inhibitor of COX. With a quantity of NaCN sufficient to bring the respiratory rate of MCDD mitochondria up to the control level, the relation between JATP and oxygen consumption (ATP/O) in MCDD mitochondria overlapped with the one in control mitochondria (Fig. 4A). In other words, when COX was slightly inhibited by NaCN, MCDD mitochondria reached the control mitochondrial yield, with equal maximal values of ATP synthesis and respiratory rates. It therefore appears that the high COX content observed in MCDD mitochondria is involved in their loss in mitochondrial efficiency. In parallel, the relation between state 4 JO2 and {Delta}p (Fig. 4B) was also measured in the presence of NaCN (Fig. 4B). In these conditions, MCDD mitochondria recovered a control JO2 even if the {Delta}p remained slightly lower, but the curve was still shifted to the left, indicating an increased proton leak.


Figure 4
View larger version (11K):
[in this window]
[in a new window]

 
Fig. 4. Consequences of a light inhibition of MCDD mitochondria respiration by cyanide (12–17 µM) on ATP/O and protonmotive force in isolated liver mitochondria. The relation between ATP synthesis and oxygen consumption (ATP/O; A) and the relation between the oxygen consumption rate and membrane potential (B) were measured in the same conditions as in Fig. 2. Respiration rate and potential were inhibited by additions of malonate. Results are expressed as means ± SE; n = 5–7 in each group.

 
Functional Consequences of the MCDD-induced Mitochondrial Uncoupling

To investigate the potential consequences of the alteration of mitochondrial energetics induced by MCDD, we investigated the ability of MCDD mitochondria to use lipids as substrates. With octanoyl-carnitine (100 µM), both state 4 (+40%; P < 0.01) and state 3 (+37%; P < 0.01) respiratory rates were increased in MCDD rat mitochondria compared with control mitochondria (Table 5).


View this table:
[in this window]
[in a new window]

 
Table 5. Liver fatty acid oxidation and antioxidant enzyme activities

 
Mitochondria are well recognized as one of the sites of ROS production. This production depends on many factors such as respiratory rate, redox status of the respiratory complexes, and membrane potential (26). We therefore studied the consequences of the MCDD-induced loss in mitochondria efficiency on H2O2 production. When expressed in picomoles H2O2 per minute per milligram mitochondrial proteins (Table 5), H2O2 production was higher in control mitochondria than in those isolated from MCDD rats (+42%). H2O2 production and O2 consumption were measured in the same conditions (buffer, substrate concentration, temperature) that allowed the calculation of the fraction of O2 turned into H2O2 instead of being reduced into water. H2O2 release per oxygen consumed was 42% lower in the MCDD group than in controls (Table 5). In this experiment, ROS measurement reflected the balance between mitochondrial H2O2 production and elimination by antioxidant systems. That the activities of GPx and mitochondrial SOD were either lowered or unchanged in MCDD rats (Table 5) ruled out the possibility that the drop in H2O2 production measured in MCDD mitochondria was associated with a more effective antioxidant system. The decreased mitochondrial H2O2 production in MCDD rats could rather be linked to the diminished mitochondrial efficiency due to the uncoupling of the respiratory chain.


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The present study has established that, in rats fed a MCDD showing typical hepatic lesions of steatohepatitis, the bioenergetics of liver mitochondria was markedly affected, leading to increased respiratory rate with various substrates and decreased energy coupling yield probably involving both redox slipping at the COX level and proton leak.

As expected, after 6 wk of MCDD and in accordance with recently published data from other groups, rats exhibited a modification in weight and fat distribution, a striking steatosis (24, 51) and inflammation (13, 14, 51), but did not show insulin resistance (data not shown; see Refs. 47 and 52).

The present data showed that, after 6 wk of MCDD, rat liver mitochondria exhibited an increased oxidative phosphorylation rate, whatever the substrate used (glutamate/malate, succinate/malate, octanoyl-carnitine). This increased respiration was not the result of mitochondrial proliferation. Indeed, citrate synthase activity, which was used as a mitochondrial marker, was unchanged between the two groups. This rise in maximal respiration rate was associated with functionally isolated COX activity (TMPD-ascorbate + DNP), as well as an increased content of cytochromes aa3. Similarly, in rats fed a 4-wk choline-deficient diet, liver mitochondria showed increased nonphosphorylating and phosphorylating respiratory rates (34). Interestingly, 7 days of this same choline-deficient diet rather led to an inhibition of nonphosphorylating oxygen consumption of liver mitochondria (21). Altogether, these results may suggest that progressive changes occur in liver mitochondrial metabolism that result in an increased quantity of respiratory chain within mitochondria and an increased respiratory activity when steatohepatitis is established for a sufficiently long period of time.

The present results showed for the first time that the increased oxidative activity of MCDD-fed rat liver mitochondria was associated with decreased oxidative phosphorylation yield. Different mechanisms could contribute to this modulation of oxygen consumption: an increase in mitochondrial quantity and in total oxidizing capacity of the liver, a change in proton leak across the inner mitochondrial membrane, and/or a decreased efficiency of the respiratory chain pumps (slipping) and/or a change in the cytochrome content of the respiratory chain. In this study, MCDD livers present no mitochondrial proliferation (unchanged citrate synthase activity), but results clearly show a drop in mitochondrial oxidative phosphorylation yield, with a parallel shift to the right hand of the ATP/O relation in liver of MCDD-fed rat mitochondria. The control mitochondria efficiency was recovered in MCDD mitochondria with a small quantity of NaCN, suggesting an implication of the COX in this energy wastage. In the same time, in both groups (control and MCDD), the relation between JO2 and {Delta}p in the nonphosphorylating state exhibited classical features (29), but the MCDD mitochondria curve was shifted to the left, suggesting some proton leak (5), and showed an increase in the nonohmic part of the relation at high potentials, possibly related to an increased physiological slipping mechanism and/or a proton leak phenomenon. Although we cannot strictly discriminate which of the redox slipping and/or proton leak is implied in this oxidative phosphorylation variation, we can assume the strong implication of the COX in the modification of the mitochondrial oxidative phosphorylation yield in MCDD rats.

Whatever the mechanism (redox slipping or proton leak) involved in energetic wastage, it is clear from this study that the increase in COX content plays a key role in the adaptative process developed in MCDD mitochondria. Indeed, 1) both COX activity and cytochrome aa3 amount were increased by 54% and 2) the addition of a small amount of NaCN on MCDD mitochondria restored both control state 4 respiratory rate and oxidative phosphorylation yield. These observations in MCDD rats were supported by previous studies reporting a relation between a modified oxidative capacity and a change in mitochondrial efficiency (17, 43, 44). Indeed, when plotting the values of mitochondria nonphosphorylating respiratory rate (liver or heart), reflecting energy wastage, against the amount of cytochrome aa3, a component of COX, obtained in the present study and in previous studies using different models [hypohyperthyroidism, polyunsaturated fatty acid deficiency, alcohol ingestion (30, 32, 37, 43)], we found a close linear correlation (r2 = 0.89; P < 0.0001, Fig. 5). Such relation supports a causal relation between COX content and the yield of oxidative phosphorylation already proposed by other authors.


Figure 5
View larger version (13K):
[in this window]
[in a new window]

 
Fig. 5. Correlation between cytochrome aa3 content and state 4 JO2 in mitochondria. Oxygen consumption rates measured in the presence of oligomycin were collected from different studies using different models of altered hepatic function (hypo/hyperthyroidism, polyunsaturated fatty acid deficiency, alcohol ingestion; see Refs. 32, 43, 44) or altered heart function (hypo/hyperthyroidism; see Refs. 30 and 37) and plotted with data obtained in the present study. Respiratory chain cytochrome aa3 concentration was measured as described in MATERIALS AND METHODS and expressed as percentage of controls. The correlation was assessed by a linear regression with r2 = 0.89, P < 0.0001.

 
However, it is important to emphasize that the {Delta}p in state 4 was not completely restored in MCDD mitochondria treated with NaCN, indicating some contribution of a proton leak. This last point was reinforced by a previous study showing a slight but significant increase in uncoupling protein (UCP) 2 mRNA in MCDD rat liver (51). Indeed, UCPs form a subfamily within the mitochondrial anion carrier protein family, which resides in the inner mitochondrial membrane and catalyzes a proton conductance that dissipates the proton electrochemical gradient built up by the respiratory chain and then partially uncouples electron transport from ATP synthesis. In our study, no significant change in UCP2 mRNA was observed (data not shown). Another factor that could contribute to proton leak was the mitochondrial membrane composition. Indeed, many studies demonstrated that a modification in phospholipids can lead to increased membrane fluidity (8, 45) and mitochondrial enzyme activity (37, 38).

Our data showed a decreased H2O2 production in the MCDD liver mitochondria, whereas antioxidant enzyme activities (SOD, CAT, GPx) in liver homogenate were either decreased or not changed in MCDD rats compared with controls. Given that mitochondria are the most important source of ROS (23), this finding somehow contradicts the general idea that, with the establishment of steatosis, hepatocytes and their mitochondria face a new environment rich in lipids, a situation favoring increased oxidative stress. Such results may indicate that, in our rodent model of steatohepatitis, adaptive mechanisms have developed within liver mitochondria to limit oxidative stress and its deleterious consequences. We have identified in MCDD rats two adaptative mechanisms leading to a decrease in ROS production by mitochondria. First, the increase in cytochrome aa3 and c decreases the kinetics constraint for electron transport trough complex I and III. As a consequence, the redox state of the electron carriers decreases and thus the probability to generate superoxides decreases (36). Second, it is well known that increased redox slipping at the COX level of the respiratory chain and proton leak across the inner mitochondrial membrane also contribute to limited ROS production (7). These two mechanisms may also have beneficial effect on the fatty liver of MCDD rats. Indeed, both mechanisms would contribute to a stimulation of the mitochondrial oxygen consumption and a drop in the NADH/NAD ratio, two phenomena known to activate the β-oxidation of lipids (19). Hence, the higher capacity of MCDD rat liver mitochondria to oxidize octanoyl-carnitine (present study) may indicate an increased capacity of the liver to use fatty acids as respiratory substrates. This higher capacity to oxidize lipids was previously described by Rizki (48) on mice receiving MCDD. This would in turn help fatty liver of long-term MCDD rats to limit steatosis.

In conclusion, after 6 wk of MCDD, rats develop a steatohepatitis with steatosis and inflammation. Our results provide evidence that, in MCDD rats, adaptations of mitochondrial bioenergetics occur in liver. Hepatic mitochondria exhibit a small decrease in efficiency of energy transfer and an increase in the COX content. Consequently, both a decrease in H2O2 production and a stimulation of oxygen consumption with fatty acids as respiratory substrates were observed. Even if the MCDD model presents steatosis and inflammation, it does not perfectly reflect human pathology. Indeed, human NASH is linked to obesity and insulin resistance, features that are not found in MCDD rats. It appears that it remains necessary to find a more physiological model that reflects human NASH pathology and the associated factors, such as obesity, dyslipidemia, and insulin resistance. Nevertheless, it results from this study that mitochondria could become a new therapeutic target of steatohepatitis since mitochondrial modifications could limit oxidative stress and lipid accumulation.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by the French Ministère de l'Enseignement, de la Recherche et de la Technologie and by a grant from the Centre National de la Recherche Scientifique.


    ACKNOWLEDGMENTS
 
We thanks Dr. A. Devin (IBGC Bordeaux II, France) and Dr. D. Roussel (Laboratoire de Physiologie Integrative, Cellulaire et Moleculaire, Lyon I, France) for scientific discussion and Dr. C. Schwimmer for English revision.


    FOOTNOTES
 

Address for reprint requests and other correspondence: C. Romestaing, Laboratoire de Physiologie Intégrative, Cellulaire et Moléculaire, Unité Mixte de Recherches 5123 Centre National de la Recherche Scientifique, Université Claude Bernard Lyon 1, Bâtiment R. Dubois, 43 bd du 11 Novembre 1918, F-69622 Villeurbanne Cedex, France (e-mail: cromestaing{at}hotmail.com)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. AebiH. Catalase in vitro. Methods Enzymol 105: 121–126, 1984.[Web of Science][Medline]
  2. BegricheK, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6: 1–28, 2006.[Web of Science][Medline]
  3. BellentaniS, Bedogni G, Miglioli L, Tiribelli C. The epidemiology of fatty liver. Eur J Gastroenterol Hepatol 16: 1087–1093, 2004.[CrossRef][Web of Science][Medline]
  4. BergmeyerHU, Bergmeyer J, Grassl M. Methods of Enzymatic Analysis. New York: Academic, 1983.
  5. BrandMD, Chien LF, Ainscow EK, Rolfe DF, Porter RK. The causes and functions of mitochondrial proton leak. Biochim Biophys Acta 1187: 132–139, 1994.[Medline]
  6. BrandMD, Chien LF, Diolez P. Experimental discrimination between proton leak and redox slip during mitochondrial electron transport. Biochem J 297: 27–29, 1994.[Web of Science][Medline]
  7. BrookesPS. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radic Biol Med 38: 12–23, 2005.[CrossRef][Web of Science][Medline]
  8. BrookesPS, Buckingham JA, Tenreiro AM, Hulbert AJ, Brand MD. The proton permeability of the inner membrane of liver mitochondria from ectothermic and endothermic vertebrates and from obese rats: correlations with standard metabolic rate and phospholipid fatty acid composition. Comp Biochem Physiol B Biochem Mol Biol 119: 325–334, 1998.[CrossRef][Medline]
  9. CaldwellSH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD Jr. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 31: 430–434, 1999.[CrossRef][Web of Science][Medline]
  10. CapitanioN, Capitanio G, De Nitto E, Villani G, Papa S. H+/e- stoichiometry of mitochondrial cytochrome complexes reconstituted in liposomes. Rate-dependent changes of the stoichiometry in the cytochrome c oxidase vesicles. FEBS Lett 288: 179–182, 1991.[CrossRef][Web of Science][Medline]
  11. ClarkJM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 122: 1649–1657, 2002.[CrossRef][Web of Science][Medline]
  12. Darley-UsmarVM, Rickwood D, Wilson MT. Mitochondria: A Practical Approach. Oxford, UK: IRL, 1987.
  13. Dela PenaA, Leclercq I, Field J, George J, Jones B, Farrell G. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129: 1663–1674, 2005.[CrossRef][Medline]
  14. Dela PenaA, Leclercq IA, Williams J, Farrell GC. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis. J Hepatol 46: 304–313, 2007.[CrossRef][Web of Science][Medline]
  15. EspieP, Guerin B, Rigoulet M. On isolated hepatocytes mitochondrial swelling induced in hypoosmotic medium does not affect the respiration rate. Biochim Biophys Acta 1230: 139–146, 1995.[Medline]
  16. FloheL, Otting F. Superoxide dismutase assays. Methods Enzymol 105: 93–104, 1984.[Web of Science][Medline]
  17. FontaineEM, Moussa M, Devin A, Garcia J, Ghisolfi J, Rigoulet M, Leverve XM. Effect of polyunsaturated fatty acids deficiency on oxidative phosphorylation in rat liver mitochondria. Biochim Biophys Acta 1276: 181–187, 1996.[Medline]
  18. FraynKN, Maycock PF. Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res 21: 139–144, 1980.[Abstract]
  19. Garcia-MartinezC, Sibille B, Solanes G, Darimont C, Mace K, Villarroya F, Gomez-Foix AM. Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs glucose oxidation. FASEB J 15: 2033–2035, 2001.[Free Full Text]
  20. GornallAG, Bardawill CJ, David MM. Determination of serum proteins by means of the Biuret reaction. J Biol Chem 177: 751–766, 1949.[Free Full Text]
  21. HensleyK, Kotake Y, Sang H, Pye QN, Wallis GL, Kolker LM, Tabatabaie T, Stewart CA, Konishi Y, Nakae D, Floyd RA. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 21: 983–989, 2000.[Abstract/Free Full Text]
  22. IpE, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38: 123–132, 2003.[CrossRef][Web of Science][Medline]
  23. JezekP, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37: 2478–2503, 2005.[CrossRef][Web of Science][Medline]
  24. KirschR, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 18: 1272–1282, 2003.[CrossRef][Web of Science][Medline]
  25. KopelmanPG. Obesity as a medical problem. Nature 404: 635–643, 2000.[Medline]
  26. KorshunovSS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416: 15–18, 1997.[CrossRef][Web of Science][Medline]
  27. LombardiB, Pani P, Schlunk FF. Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lipid Res 9: 437–446, 1968.[Abstract]
  28. NichollsDG. Hamster brown-adipose tissue mitochondria. The control of respiration and proton electrochemical potential gradient by possible physiological effectors of the proton conductance of the inner membrane. Eur J Biochem 49: 573–583, 1974.[Web of Science][Medline]
  29. NichollsDG. The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat-liver mitochondria as determined by ion distribution. Eur J Biochem 50: 305–315, 1974.[Web of Science][Medline]
  30. NishikiK, Erecinska M, Wilson DF, Cooper S. Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid, and hyperthyroid rats. Am J Physiol Cell Physiol 235: C212–C219, 1978.[Abstract/Free Full Text]
  31. NogueiraV, Piquet MA, Devin A, Fiore C, Fontaine E, Brandolin G, Rigoulet M, Leverve XM. Mitochondrial adaptation to in vivo polyunsaturated fatty acid deficiency: increase in phosphorylation efficiency. J Bioenerg Biomembr 33: 53–61, 2001.[CrossRef][Web of Science][Medline]
  32. NogueiraV, Rigoulet M, Piquet MA, Devin A, Fontaine E, Leverve XM. Mitochondrial respiratory chain adjustment to cellular energy demand. J Biol Chem 276: 46104–46110, 2001.[Abstract/Free Full Text]
  33. NogueiraV, Walter L, Averet N, Fontaine E, Rigoulet M, Leverve XM. Thyroid status is a key regulator of both flux and efficiency of oxidative phosphorylation in rat hepatocytes. J Bioenerg Biomembr 34: 55–66, 2002.[CrossRef][Web of Science][Medline]
  34. OliveiraCP, Coelho AM, Barbeiro HV, Lima VM, Soriano F, Ribeiro C, Molan NA, Alves VA, Souza HP, Machado MC, Carrilho FJ. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res 39: 189–194, 2006.[Web of Science][Medline]
  35. PapaS, Capitanio N, Capitanio G, De Nitto E, Minuto M. The cytochrome chain of mitochondria exhibits variable H+/e- stoichiometry. FEBS Lett 288: 183–186, 1991.[CrossRef][Web of Science][Medline]
  36. PapaSG, Guerrieri F, Capitanio N. A possible role of slips in cytochrome c oxidase in the antioxygen defense system of the cell. Biosci Rep 17: 23–31, 1997.[CrossRef][Web of Science][Medline]
  37. ParadiesG, Ruggiero FM, Dinoi P, Petrosillo G, Quagliariello E. Decreased cytochrome oxidase activity and changes in phospholipids in heart mitochondria from hypothyroid rats. Arch Biochem Biophys 307: 91–95, 1993.[CrossRef][Web of Science][Medline]
  38. ParadiesG, Ruggiero FM, Petrosillo G, Quagliariello E. Enhanced cytochrome oxidase activity and modification of lipids in heart mitochondria from hyperthyroid rats. Biochim Biophys Acta 1225: 165–170, 1994.[Medline]
  39. PessayreD, Fromenty B. NASH: a mitochondrial disease. J Hepatol 42: 928–940, 2005.[CrossRef][Web of Science][Medline]
  40. PiccoliCS, R; Boffoli D; Capitanio N. Control by cytochrome c oxidase of the cellular oxidative phosphorylation system depends on the mitochondrial energy state. Biochem J 396: 573–583, 2006.[CrossRef][Web of Science][Medline]
  41. PietrobonD, Azzone GF, Walz D. Effect of funiculosin and antimycin A on the redox-driven H+-pumps in mitochondria: on the nature of "leaks." Eur J Biochem 117: 389–394, 1981.[Web of Science][Medline]
  42. PietrobonD, Zoratti M, Azzone GF. Molecular slipping in redox and ATPase H+ pumps. Biochim Biophys Acta 723: 317–321, 1983.[Medline]
  43. PiquetMA, Nogueira V, Devin A, Sibille B, Filippi C, Fontaine E, Roulet M, Rigoulet M, Leverve XM. Chronic ethanol ingestion increases efficiency of oxidative phosphorylation in rat liver mitochondria. FEBS Lett 468: 239–242, 2000.[CrossRef][Web of Science][Medline]
  44. PiquetMA, Roulet M, Nogueira V, Filippi C, Sibille B, Hourmand-Ollivier I, Pilet M, Rouleau V, Leverve XM. Polyunsaturated fatty acid deficiency reverses effects of alcohol on mitochondrial energy metabolism. J Hepatol 41: 721–729, 2004.[CrossRef][Web of Science][Medline]
  45. PorterRK, Hulbert AJ, Brand MD. Allometry of mitochondrial proton leak: influence of membrane surface area and fatty acid composition. Am J Physiol Regul Integr Comp Physiol 271: R1550–R1560, 1996.[Abstract/Free Full Text]
  46. PortincasaP, Grattagliano I, Palmieri VO, Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem 38: 203–217, 2005.[CrossRef][Web of Science][Medline]
  47. RinellaME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 40: 47–51, 2004.[Web of Science][Medline]
  48. RizkiG, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Turner SM, Badger TM, Pitas RE, Maher JJ. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J Lipid Res 47: 2280–2290, 2006.[Abstract/Free Full Text]
  49. SanyalAJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183–1192, 2001.[CrossRef][Web of Science][Medline]
  50. SrereP. Citrate synthase. In: Methods in Enzymology, edited by Lowenstein JM. New York: Academic, 1969, p. 3–11.
  51. StarkelP, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, Horsmans Y. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 39: 538–546, 2003.[CrossRef][Web of Science][Medline]
  52. TahanV, Yavuz D, Imeryuz N, Avsar E, Tozun N. Oral glucose tolerance deteriorates in rats fed with methionine choline deficient diet. J Hepatol 41: 352–353, 2004.[CrossRef][Web of Science][Medline]
  53. TappelAL. Glutathione peroxidase and hydroperoxides. Methods Enzymol 52: 506–513, 1978.[Medline]
  54. WeltmanMD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111: 1645–1653, 1996.[CrossRef][Web of Science][Medline]
  55. WilliamsJN Jr. A method for the simultaneous quantitative estimation of cytochromes a, b, c1, and c in mitochondria. Arch Biochem Biophys 107: 537–543, 1964.[CrossRef][Web of Science][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/E110    most recent
00407.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romestaing, C.
Right arrow Articles by Sibille, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romestaing, C.
Right arrow Articles by Sibille, B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.